Derniers articles listés par NCBI PubMed sur les maladies inflammatoires du foie et des voies biliaires (en anglais)
Qu’est-ce que PubMed?
Pubmed est la Bibliothèque Nationale de Médecine américaine. Pubmed incorpore plus de 24 millions d’extraits de littérature biomédicale issus du service en ligne MEDLINE, de journaux et livres scientifiques. Les extraits incorporent parfois des liens vers les textes intégraux des articles ou vers les sites web des éditeurs. Ces documents sont des publications scientifiques relatant l’avancée de la recherche sur les maladies inflammatoires du foie et des voies biliaires. Ils sont relayés ici sur le site d’albi afin que les malades comme les professionnels de la santé se fassent une idée des thématiques d’études et des avancées de la recherche. Il faut bien comprendre que ces communications sont des résultats de recherches ponctuelles, qui doivent être validés par d’autres études, pour éventuellement déboucher sur des innovations thérapeutiques quelques années plus tard. Si vous êtes malade, il est évident que ces informations ne peuvent pas être prises en compte pour prendre l’initiative d’une quelconque modification de votre traitement, modification qui ne peut se faire que sous avis médical.
> création: PhDu, albi, le 15/10/2013
> rédaction: PhDu, albi, le 15/10/2013
What is PubMed?
PubMed is the US National Library of Medicine. PubMed comprises more than 24 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
pubmed
- Downregulation of hepatic stem cell factor by Vivo-Morpholino treatment inhibits mast cell migration and decreases biliary damage/senescence and liver fibrosis in Mdr2-/- mice.
- Association of solid-phase assays to the indirect immunofluorescence in primary biliary cholangitis diagnosis: Results of an Italian multicenter study.
- Autoimmune hepatitis in patients with human immunodeficiency virus infection: A systematic review of the published literature.
- Clinical profile and outcome of primary sclerosing cholangitis: A single-centre experience from western India.
- Risk stratification in primary sclerosing cholangitis: It's time to move on from replicating imperfection and break the glass ceiling.
- Observed or Predicted Albendazole Hepatotoxicity as an Indication for a Resection Procedure in Hepatic Hydatid Disease - A Short Series of Cases.
- Unchecked immunity: a unique case of sequential immune-related adverse events with Pembrolizumab.
- Drug Therapies for Chronic Cholestatic Liver Diseases.
- IgG4-Related Sclerosing Cholangitis: A Clinical and Imaging Review.
- Patterns of serum lipids derangements and cardiovascular risk assessment in patients with primary biliary cholangitis.
- Deficiency of canonical Wnt/β-catenin signaling in hepatic dendritic cells triggers autoimmune hepatitis.
- Application of Risk Scores in the Daily Management of Primary Biliary Cholangitis: Response to Corpechot and Chazouillères.
- Fas, FasL and Foxp3 gene expression in post-liver transplant autoimmune hepatitis patients with and without acute rejection.
- Workup and Management of Immune-Mediated Hepatobiliary Pancreatic Toxicities That Develop During Immune Checkpoint Inhibitor Treatment.
- Inflammatory Bowel Disease in Children with Elevated Serum Gamma Glutamyltransferase Levels.
- Acute liver failure.
- A National Hospital-Based Study of Hospitalized Patients With Primary Biliary Cholangitis.
- High-Throughput Immunogenetics Reveals a Lack of Physiological T Cell Clusters in Patients With Autoimmune Cytopenias.
- Overexpression of MHCII by hepatocytes in Alcoholic Hepatitis (AH) compared to Non-alcoholic Steatohepatitis (NASH) and normal controls.
- Primary Sclerosing Cholangitis in Children With Inflammatory Bowel Diseases is Associated with Milder Clinical Activity but More Frequent Subclinical Inflammation and Growth Impairment.
- Patterns and prevalence of dyslipidemia in patients with different etiologies of chronic liver disease.
- Race/Ethnicity and Insurance-Specific Disparities in In-Hospital Mortality Among Adults with Primary Biliary Cholangitis: Analysis of 2007-2014 National Inpatient Sample.
- [Meta Analysis of Risks of Cardiocerebral Vascular Events in Patients with Primary Biliary Cholangitis].
- The efficacy and adverse effects of budesonide in remission induction treatment of autoimmune hepatitis: a retrospective study.
- [No significant association between obesity and long-term outcome of coronary artery bypass grafting].
- Ursodeoxycholic acid in pregnancy ?
- EUS-guided gallbladder drainage in patients with cirrhosis: results of a multicenter retrospective study.
- Effectiveness of bezafibrate and ursodeoxycholic acid in patients with primary biliary cholangitis: a meta-analysis of randomized controlled trials.
- Acute onset of autoimmune hepatitis in children and adolescents.
- The significance of ANCA positivity in patients with inflammatory bowel disease.
- A Bile Duct-on-a-Chip with Organ-Level Functions.
- Galectin-9 in autoimmune hepatitis: Correlation between serum levels of galectin-9 and M2BPGi in patients with autoimmune hepatitis.
- Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis (PSC): a Comprehensive Review.
- HLA-DRB1 GENE POLYMORPHISMS IN PEDIATRIC PATIENTS WITH TYPE 1 AUTOIMMUNE HEPATITIS AND TYPE 1 AUTOIMMUNE HEPATITIS OVERLAP SYNDROME WITH AUTOIMMUNE CHOLANGITIS.
- Association between serum IgG level and clinical course in primary sclerosing cholangitis.
- UPDATE OF THE BRAZILIAN SOCIETY OF HEPATOLOGY RECOMMENDATIONS FOR DIAGNOSIS AND MANAGEMENT OF AUTOIMMUNE DISEASES OF THE LIVER.
- Development of Leiomyosarcoma in a Patient Treated with Azathioprine.
- A Study of Effect of Long-term Oral Steroids on Intraocular Pressure in Children with Autoimmune Hepatitis.
- Outcomes of Liver Transplant Candidates with Primary Biliary Cholangitis: The Data from the Scientific Registry of Transplant Recipients.
- Association Between Indefinite Dysplasia and Advanced Neoplasia in Patients With Inflammatory Bowel Diseases Undergoing Surveillance.
- Sensory neuronopathy as a rare presentation of primary biliary cholangitis.
- Omentin, vaspin and irisin in chronic liver diseases.
- Fatigue in Primary Biliary Cholangitis: no Place for Rituximab.
- A Patient with Type 3 Autoimmune Polyglandular Syndrome who Developed Systemic Lupus Erythematosus 8 years after the Diagnosis of Autoimmune Hepatitis.
- Prediction of Transplant-Free Survival through Albumin-Bilirubin Score in Primary Biliary Cholangitis.
- Phosphatidylcholine Passes by Paracellular Transport to the Apical Side of the Polarized Biliary Tumor Cell Line Mz-ChA-1.
- Increased incidence of autoimmune hepatitis is associated with wider use of biological drugs.
- Efficacy and safety of 3-year denosumab therapy for osteoporosis in patients with autoimmune liver diseases.
- Overlap Syndrome Involving Systemic Lupus Erythematosus and Autoimmune Hepatitis in Children: A Case Report and Literature Review.
- Safety of vedolizumab in liver transplant recipients: A systematic review.
- A Brief Reflection on Continuous vs Binary Risk Indicators in Primary Biliary Cholangitis.
- Clinical Pathologic Mismatch in a TNF-α Inhibitor-Associated Drug Reaction
- Differentiating pediatric autoimmune liver diseases by quantitative magnetic resonance cholangiopancreatography.
- Foxp3⁺ Treg Cells Are Associated with Pathological Process of Autoimmune Hepatitis by Activating Methylation Modification in Autoimmune Hepatitis Patients.
- The Potential Effects of Diabetes Mellitus on Liver Fibrosis in Patients with Primary Biliary Cholangitis.
- Factors Associated With Progression and Outcomes of Early-stage Primary Biliary Cholangitis.
- Redox regulation of hepatic NLRP3 inflammasome activation and immune dysregulation in trichloroethene-mediated autoimmunity.
- Editorial: gut microbial profile associated with primary sclerosing cholangitis-what is new and how do we progress from here? Authors' reply.
- Editorial: gut microbial profile associated with primary sclerosing cholangitis-what is new and how do we progress from here?
- Characteristics and outcome of primary sclerosing cholangitis associated with inflammatory bowel disease in Asian children.
- The long-term outcomes of pediatric-onset primary sclerosing cholangitis: a single center experience in Japan.
- [Review of clinical guidelines of primary sclerosing cholangitis].
- Experience in Liver Transplantation Due to Primary Sclerosing Cholangitis: A Single Center Experience.
- Adverse events with fatal outcome associated with alemtuzumab treatment in multiple sclerosis.
- Curcumin mitigates the epithelial-to-mesenchymal transition in biliary epithelial cells through upregulating CD109 expression.
- Ursodeoxycholic Acid Alters Bile Acid and Fatty Acid Profiles in a Mouse Model of Diet-Induced Obesity.
- Impact of paediatric onset primary sclerosing cholangitis on clinical course and outcome of inflammatory bowel disease: a case-control population-based study in Finland.
- Preponderance of CTLA4 Variation Associated With Autosomal Dominant Immune Dysregulation in the MYPPPY Motif.
- Incidence, prevalence, and outcome of primary biliary cholangitis in a nationwide Swedish population-based cohort.
- Autoimmune Hepatitis in Special Populations: In Pediatrics and Across Different Ethnicities/Races.
- Autoimmune Hepatitis Beyond Steroids: Effective Trial Design and Attention to Quality of Life.
- Genetic and Environmental Risk Factors for Autoimmune Hepatitis.
- Long-Term Outcomes of Autoimmune Hepatitis.
- Direct-Acting Antiviral Treatment of Patients with Hepatitis C Resolves Serologic and Histopathologic Features of Autoimmune Hepatitis.
- Enhanced Th17 Responses in Patients with Autoimmune Hepatitis.
- Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-escalation stage of a multicentre, open-label, phase 1a/b trial.
- RANK/RANKL Acts as a Protective Factor by Targeting Cholangiocytes in Primary Biliary Cholangitis.
- Cholestatic liver disease results increased production of reactive aldehydes and an atypical periportal hepatic antioxidant response.
- High occurrence of small intestinal bacterial overgrowth in primary biliary cholangitis.
- Early detection of intrahepatic cholangiocarcinoma.
- Vitamin D supplementation for the prevention or depletion of side effects of therapy with alemtuzumab in multiple sclerosis.
- Liver biopsy in primary biliary cholangitis: is sinusoidal fibrosis the missing key?
- Treatment of Pruritus Secondary to Liver Disease.
- Immunoglobulin G4-related Liver Disease Overlapping with Non-alcoholic Steatohepatitis that was Diagnosed Simultaneously with Autoimmune Pancreatitis: A Case Report and Review of the Literature.
- Clustering of immune-mediated diseases in sarcoidosis.
- Long-Standing Unresolved Primary Biliary Cholangitis Leading to Systemic Amyloid A Amyloidosis With Predominant Liver Involvement: A Death Case.
- Cannabidiol (CBD) Consumption and Perceived Impact on Extrahepatic Symptoms in Patients with Autoimmune Hepatitis.
- Immunomodulatory drugs in pregnancy and lactation.
- Acute Severe Autoimmune Hepatitis: Corticosteroids or Liver Transplantation? The importance of the absence of any sign of encephalopathy.
- Immunoglobulin G4-related hepatobiliary disease.
- Checkpoint inhibitor-induced liver injury: A novel form of liver disease emerging in the era of cancer immunotherapy.
- [Study of the correlation between elevated level of T-bet expression and liver damage in peripheral plasma cells of patients with autoimmune hepatitis].
- Long-Term Use of Azathioprine in the Management of Autoimmune Hepatitis.
- Ursodeoxycholic acid and cancer: From chemoprevention to chemotherapy.
- [Treatment of Fulminant Hepatic Failure - Myth and Facts].
- Variance component analysis of circulating miR-122 in serum from healthy human volunteers.
- Response to "High dose Intravenous Corticosteroids in AS-AIH".
- Biliary endoscopy in the management of primary sclerosing cholangitis and its complications.
- Parvovirus B19 Myocarditis: Looking Beyond the Heart.
- Inflammatory Bowel Disease Types Differ in Markers of Inflammation, Gut Barrier and in Specific Anti-Bacterial Response.
- StatPearls
- Human biodistribution, dosimetry, radiosynthesis and quality control of the bile acid PET tracer [N-methyl-11C]cholylsarcosine.
- Peribiliary gland niche participates in biliary tree regeneration in mouse and in human primary sclerosing cholangitis.
- Risk factors for and management of ischemic-type biliary lesions following orthotopic liver transplantation: A single center experience.
- Response to "Corticosteroids for Acute Severe Autoimmune Hepatitis".
- All That Glitters is Not Gold in Vedolizumab Therapy for Patients With Inflammatory Bowel Diseases and Primary Sclerosing Cholangitis.
- Barriers to implementation of stratified care in primary biliary cholangitis: a scoping exercise.
- The risk of liver cancer in autoimmune liver diseases.
- Early ALT response to corticosteroid treatment distinguishes idiosyncratic Drug-induced Liver Injury from Autoimmune Hepatitis.
- Depression in autoimmune hepatitis: a need for detailed psychiatric assessment.
- Etiological Patterns, Liver Fibrosis Stages and Prescribing Patterns of Hepato-Protective Agents in Indian Patients with Chronic Liver Disease.
- Effects of Antibiotic Therapy in Primary Sclerosing Cholangitis with and without Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
- Listeria brain abscess in a patient with autoimmune hepatitis.
- Successful Management of Patients with Co-existent Graves' Disease and Autoimmune Hepatitis.
- A Study of Hormonal Abnormalities in Chronic Liver Disease.
- Diseases of the Abdomen and Pelvis 2018-2021: Diagnostic Imaging - IDKD Book
- Resolution of HCV-Autoimmune Hepatitis Overlap Syndrome With Antiviral TreatmentA Paired Liver Biopsy Study.
- AGA Institute Clinical Practice Update: Surveillance for Hepatobiliary Cancers in Patients with Primary Sclerosing Cholangitis.
- Fecal Microbiota Transplantation in Patients With Primary Sclerosing Cholangitis: The Next Steps in This Promising Story.
- Excellent safety and effectiveness of high dose myrcludex-b monotherapy administered for 48 weeks in hdv related compensated cirrhosis: a case report of three patients.
- UGT-dependent regioselective glucuronidation of ursodeoxycholic acid and obeticholic acid and selective transport of the consequent acyl glucuronides by OATP1B1 and 1B3.
- Immune inhibitory proteins and their pathogenic and therapeutic implications in autoimmunity and autoimmune hepatitis.
- Autoimmune hepatitis following Epstein-Barr virus infection: a diagnostic dilemma.
- Hepatotoxicity of immune check point inhibitors: Approach and management.
- Autoimmune liver disease and the enteric microbiome.
- The Impact of Inflammatory Bowel Disease in Canada 2018: Extra-intestinal Diseases in IBD.
- A Cholangioscopy-Based Novel Classification System for the Phenotypic Stratification of Dominant Bile Duct Strictures in Primary Sclerosing Cholangitis-the Edmonton Classification.
- High Prevalence of Autoimmune Gastritis in Patients with Nonalcoholic Steatohepatitis.
- Autoimmune Hepatitis Refractory to Treatment Due to Underlying Grave's Disease.
- Autoimmune Hepatitis (AIH) in Acquired Immune Deficiency Syndrome (AIDS): A Case Report and Review of Literature.
- Guideline review: British Society of Gastroenterology/UK-PBC Primary Biliary Cholangitis treatment and management guidelines.
- Impact of peroral cholangioscopy on the management of indeterminate biliary conditions: a multicentre prospective trial.
- Meta-Analysis of Antinuclear Antibodies in the Diagnosis of Antimitochondrial Antibody-Negative Primary Biliary Cholangitis.
- Primary biliary cholangitis with autoimmune hepatitis features: What's the appropriate criteria to evaluate the treatment-response?
- Diagnosis and management of IgG4-related disease.
- Large-duct cholangiopathies: aetiology, diagnosis and treatment.
- Muscle performance and fatigue in compensated chronic liver disease.
- A case of primary biliary cholangitis overlapping with type 2 autoimmune hepatitis.
- Relation Between Immunohistochemical Expression of Hippo Pathway Effectors and Chronic Hepatitis Induced Fibrosis in Egyptian Patients.
- Validation, Clinical Utility and Limitations of the Amsterdam-Oxford Model for Primary Sclerosing Cholangitis.
- Prospective comparison of transient, point shear wave, and magnetic resonance elastography for staging liver fibrosis.
- Concomitant Sjögren's Syndrome Was Not Associated with a Poorer Response or Outcomes in Ursodeoxycholic Acid-Treated Patients with Primary Biliary Cholangitis.
- Autoimmune hepatitis, fatty liver, and Fukushima.
- The Epidemiology and Clinical Manifestations of Autoimmunity in Selective IgA Deficiency.
- Terry's nails as the first clinical sign of autoimmune hepatitis.
- Diagnosing autoimmune hepatitis in paediatric patients - we still haven't found what we are looking for.
- Rheumatologic manifestations of hepatic diseases.
- Pharmacologic management of primary sclerosing cholangitis: what's in the pipeline?
- Infectious mononucleosis (Epstein-Barr virus infection) and chronic hepatitis.
- Cytotoxic KLRG1 expressing lymphocytes invade portal tracts in primary biliary cholangitis.
- Semisynthetic bile acids: a new therapeutic option for metabolic syndrome.
- Celiac disease: What the Indian pediatricians know about the disease.
- Among Patients with Undetectable Hepatitis B Surface Antigen and Hepatocellular Carcinoma, a High Proportion Has Integration of HBV DNA into Hepatocyte DNA and No Cirrhosis.
- Unfavorable prognosis of patients with acute liver injury due to drug-induced liver injury and acute exacerbation of HBV infection.
- Secretin/secretin receptor signaling mediates biliary damage and liver fibrosis in early-stage primary biliary cholangitis.
- Consistent alterations in faecal microbiomes of patients with primary sclerosing cholangitis independent of associated colitis.
- Synthesis and biological evaluation of (1,2,4)triazole[4,3-a]pyridine derivatives as potential therapeutic agents for concanavalin A-induced hepatitis.
- Selective deletion of ENTPD1/CD39 in macrophages exacerbates biliary fibrosis in a mouse model of sclerosing cholangitis.
- Roles of circular RNAs in immune regulation and autoimmune diseases.
- Alterations of the bile microbiome in primary sclerosing cholangitis.
- Autoimmune hepatitis: Diagnostic criteria and serological testing.
- Primary sclerosing cholangitis: One disease or several?
- Autoimmune hepatitis: Histopathology.
- Acute Severe Autoimmune Hepatitis: Corticosteroids or Liver Transplantation?
- Validation of Risk Scoring Systems in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis.
- Adult Living Donor Liver Re-Transplant Following Late Pediatric Liver Transplant Failure: A Case Report.
- Quantitative spleen and liver volume changes predict survival of patients with primary sclerosing cholangitis.
- Potential of Intestine-Selective FXR Modulation for Treatment of Metabolic Disease.
- Autoimmune hepatitis treatment in the elderly: A systematic review.
- Gal-3 Deficiency Suppresses Novosphyngobium aromaticivorans Inflammasome Activation and IL-17 Driven Autoimmune Cholangitis in Mice.
- The Contribution of B Cells in Autoimmune Liver Diseases.
- GPBAR1 functions as gatekeeper for liver NKT cells and provides counterregulatory signals in mouse models of immune-mediated hepatitis.
- Effects of adenovirus-induced hepatocyte damage on chronic bile duct inflammation in a sclerosing cholangitis mouse model.
- Cancer risk, screening and surveillance in primary sclerosing cholangitis.
- Clustering of immune-mediated diseases in sarcoidosis.
- Clinical impact of digital cholangioscopy in management of indeterminate biliary strictures and complex biliary stones: a single-center study.
- Hepatoprotective effect of capsaicin against concanavalin A-induced hepatic injury via inhibiting oxidative stress and inflammation.
- Liver dysfunction induced by Levothyroxine Sodium Tablets (Euthyrox®) in a hypothyroid patient with Hashimoto's thyroiditis: case report and literature review.
- Pathogenesis, diagnosis and treatment of premalignant and malignant stages of cholangiocarcinoma in primary sclerosing cholangitis.
- Association of Interleukin-6 and Interleukin-1 Family Gene Polymorphisms in Autoimmune Hepatitis.
- Prevalence, Risk Factors, and Survival of Patients with Intrahepatic Cholangiocarcinoma.
- Novel HLA Class I Alleles Outside the Extended DR3 Haplotype Are Protective against Autoimmune Hepatitis.
- Quantitative microbiome profiling disentangles inflammation- and bile duct obstruction-associated microbiota alterations across PSC/IBD diagnoses.
- Fecal Microbiota Transplantation for Primary Sclerosing Cholangitis-A Beautiful but Incomplete Story.
- Association between Smoking and Risk of Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis.